Myocardial ischemia in Kawasaki disease: Evaluation with dipyridamole stress technetium 99m tetrofosim scintigraphy

Journal of Nuclear Cardiology

Volumn 9, Issue 6, 2002, Pages 632-637

  Fukuda, Tsuyoshi ^a   Ishibashi, Masatoshi ^a   Yokoyama, Tatsuo ^a   Otaki, Masaki ^b   Shinohara, Tohru ^a   Nakamura, Yoshihide ^a   Miyake, Toshiharu ^a   Kudoh, Takashi ^b   Oku, Hidetaka ^b  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dipyridamole; Kawasaki disease; Scintigraphy; Technetium 99m tetrofosmin

Indexed keywords

AMINOPHYLLINE; DIPYRIDAMOLE; TETROFOSMIN TC 99M; THALLIUM 201;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; CHILD; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; FATIGUE; FEMALE; FLUSHING; HEADACHE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HEART VENTRICLE FUNCTION; HUMAN; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NAUSEA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT DEPRESSION; THORAX PAIN;

EID: 0036868650     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2002.125915     Document Type: Article

References (19)

1. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986;315:341-7.
2. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991;324:1633-9.
3. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996;94:1379-85.
4. Kato H, Ichinose E, Kawasaki T. Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J Pediatr 1986; 108:923-7.
5. Kegel SM, Dorsey TJ, Rowen M, Taylor WE, Cardiac death in mucocutaneous lymph node syndrome. Am J Cardiol 1977;40:282-6.
6. VanTrain KF, Berman DS, Garcia EV, Berger HJ, Sands MJ, Friedman JD, et al. Quantitative analysis of stress thallium-201 myocardial scintigrams: a multicenter trial. J Nucl Med 1986;27:17-25.
7. 201T1 myocardial tomography. Circulation 1989;80:615-24.
8. Fukuda T, Akagi T, Ishibashi M, Inoue O, Sugimura T, Kato H. Noninvasive evaluation of myocardial ischemia in Kawasaki disease: comparison between dipyridamole stress thallium imaging and exercise stress testing. Am Heart J 1998;135:482-7.
9. American Heart Association Committee Report. A reporting system on patients evaluated for coronary artery disease. Circulation 1975;51:7-40.
10. Tamaki N, Ohtani H, Yonekura Y, Nohara R, Kambara H, Kawai C, et al. Significance on fill-in after thallium-201 reinjection following delayed imaging: comparison with regional wall motion and angiographic findings. J Nucl Med 1990;31:1617-23.
11. Garcia EV, Train KV, Maddahi J, Prigent F, Friedman J, Areeda J, et al. Quantification of rotational thallium-201 myocardial tomography. J Nucl Med 1985;26:17-26.
12. Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics 1978;61:100-7.
13. Sugimura T, Kato H, Inoue O, Fukuda T, Sato N, Ishii M, et al. Intravascular ultrasound of coronary arteries in children. Assessment of the wall morphology and the lumen after Kawasaki disease. Circulation 1994;89:258-65.
14. Berman DS. Technetium-99m myocardial perfusion imaging agents and their relations to thallium-201. Am J Cardiol 1990; 66:1E-4E.
15. Higley B, Smith FW, Smith T, Gemmel HG, Gupta PD, Gvozdanovic DV, Graham D, Hinge D, Davidson J, Lahiri A. Technetium-99m-1,2-bis[bis(2-ethoxyethyl)phosphino] ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993;34:30-8.
16. Jain D, Wackers FJ. Th, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol. J Nucl Med 1993;34:1254-9.
17. Kelly JD, Forster AM, Higley B, Archer CM, Booker FS, Canning LR, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993;34:222-7.
18. Homma S, Gilliland Y, Guiney TE, Strauss HW, Boucher CA. Safety of intravenous dipyridamole for stress testing with thallium imaging. Am J Cardiol 1987;59:152-4.
19. Gould KL. Noninvasive assessment of coronary stenosis by myocardial perfusion imaging during pharmacologic coronary vasodilatation. I. Physiologic basis and experimental validation. Am J Cardiol 1978;41:267-78.